Hubert C. Chen

Filings by Hubert C. Chen span 2 companies, the busiest being Forte Biosciences, Inc. and Metacrine, Inc. We count 6 filings; the first trade dates from 20 May 2021 and the latest from 1 January 2024.

Every open-market trade on record is a purchase: 1 purchase worth €9,685, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 share grant and 4 option exercises.

The latest filing, published on 3 January 2024, reports an option exercise in Forte Biosciences, Inc. The most recent open-market purchase was published on 20 May 2021, 1,977 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.